FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

37592211000001108: Lorlatinib 25mg tablets 120 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
399751000001112 Lorlatinib 25mg tablets 120 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
399761000001110 Lorlatinib 25mg tablets 120 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lorlatinib 25mg tablets 120 tablet Has VMP Lorlatinib 25mg tablets true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets 120 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets 120 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets 120 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets 120 tablet Has specific active ingredient Lorlatinib false Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets 120 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets 120 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets 120 tablet Has specific active ingredient Lorlatinib true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Lorviqua 25mg tablets (Pfizer Ltd) 120 tablet 12 x 10 tablets Is a True Lorlatinib 25mg tablets 120 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start